 | • レポートコード：MRC2012B0681 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肺がん診断検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。肺がん診断検査の種類別市場規模（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他）、用途別市場規模（精密医療、個別化医療、がんモニタリング）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Advpharma Inc、Epigenomics AG、DiagnoCure Inc. (Inactive)、AIT Austrian Institute of Technology GmbH、Emory University、Courtagen Life Sciences Inc、HalioDx SAS、BioMarker Strategies LLC、BioMark Diagnostics Inc.、GlycoZym、Louisville Bioscience, Inc.、Mayo Clinic US、 ・地域別グローバル市場分析 2015年-2020年 ・肺がん診断検査の北米市場（アメリカ、カナダ、メキシコ） ・肺がん診断検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肺がん診断検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肺がん診断検査の南米市場（ブラジル、アルゼンチン） ・肺がん診断検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他 ・用途別分析：精密医療、個別化医療、がんモニタリング ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Lung Cancer Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lung Cancer Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lung Cancer Diagnostic Tests market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lung Cancer Diagnostic Tests market has been segmented into:
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
By Application, Lung Cancer Diagnostic Tests has been segmented into:
Precision Medicine
Personalized Medicine
Cancer Monitoring
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lung Cancer Diagnostic Tests market presented in the report. This section sheds light on the sales growth of different regional and country-level Lung Cancer Diagnostic Tests markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lung Cancer Diagnostic Tests market.
The report offers in-depth assessment of the growth and other aspects of the Lung Cancer Diagnostic Tests market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Lung Cancer Diagnostic Tests Market Share Analysis
Lung Cancer Diagnostic Tests competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lung Cancer Diagnostic Tests sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lung Cancer Diagnostic Tests sales, revenue and market share for each player covered in this report.
The major players covered in Lung Cancer Diagnostic Tests are:
Advpharma Inc
Epigenomics AG
DiagnoCure Inc. (Inactive)
AIT Austrian Institute of Technology GmbH
Emory University
Courtagen Life Sciences Inc
HalioDx SAS
BioMarker Strategies LLC
BioMark Diagnostics Inc.
GlycoZym
Louisville Bioscience, Inc.
Mayo Clinic US
Table of Contents
1 Lung Cancer Diagnostic Tests Market Overview
1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Type
1.2.1 Global Lung Cancer Diagnostic Tests Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Type in 2019
1.2.3 Immunoassays
1.2.4 Flow Cytometry
1.2.5 Rapid Tests
1.2.6 Molecular Assays
1.2.7 Tissue Arrays
1.2.8 Circulating Tumor Cells
1.2.9 Pharmacodiagnostics
1.2.10 Biomarkers
1.2.11 Other Diagnostics Methods
1.3 Global Lung Cancer Diagnostic Tests Market by Application
1.3.1 Overview: Global Lung Cancer Diagnostic Tests Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Global Lung Cancer Diagnostic Tests Market by Regions
1.4.1 Global Lung Cancer Diagnostic Tests Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lung Cancer Diagnostic Tests (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lung Cancer Diagnostic Tests Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lung Cancer Diagnostic Tests Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lung Cancer Diagnostic Tests Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lung Cancer Diagnostic Tests Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lung Cancer Diagnostic Tests Status and Prospect (2015-2025)
2 Company Profiles
2.1 Advpharma Inc
2.1.1 Advpharma Inc Details
2.1.2 Advpharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advpharma Inc SWOT Analysis
2.1.4 Advpharma Inc Product and Services
2.1.5 Advpharma Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.2 Epigenomics AG
2.2.1 Epigenomics AG Details
2.2.2 Epigenomics AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Epigenomics AG SWOT Analysis
2.2.4 Epigenomics AG Product and Services
2.2.5 Epigenomics AG Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.3 DiagnoCure Inc. (Inactive)
2.3.1 DiagnoCure Inc. (Inactive) Details
2.3.2 DiagnoCure Inc. (Inactive) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 DiagnoCure Inc. (Inactive) SWOT Analysis
2.3.4 DiagnoCure Inc. (Inactive) Product and Services
2.3.5 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.4 AIT Austrian Institute of Technology GmbH
2.4.1 AIT Austrian Institute of Technology GmbH Details
2.4.2 AIT Austrian Institute of Technology GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AIT Austrian Institute of Technology GmbH SWOT Analysis
2.4.4 AIT Austrian Institute of Technology GmbH Product and Services
2.4.5 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.5 Emory University
2.5.1 Emory University Details
2.5.2 Emory University Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Emory University SWOT Analysis
2.5.4 Emory University Product and Services
2.5.5 Emory University Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.6 Courtagen Life Sciences Inc
2.6.1 Courtagen Life Sciences Inc Details
2.6.2 Courtagen Life Sciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Courtagen Life Sciences Inc SWOT Analysis
2.6.4 Courtagen Life Sciences Inc Product and Services
2.6.5 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.7 HalioDx SAS
2.7.1 HalioDx SAS Details
2.7.2 HalioDx SAS Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 HalioDx SAS SWOT Analysis
2.7.4 HalioDx SAS Product and Services
2.7.5 HalioDx SAS Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioMarker Strategies LLC
2.8.1 BioMarker Strategies LLC Details
2.8.2 BioMarker Strategies LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioMarker Strategies LLC SWOT Analysis
2.8.4 BioMarker Strategies LLC Product and Services
2.8.5 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.9 BioMark Diagnostics Inc.
2.9.1 BioMark Diagnostics Inc. Details
2.9.2 BioMark Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BioMark Diagnostics Inc. SWOT Analysis
2.9.4 BioMark Diagnostics Inc. Product and Services
2.9.5 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlycoZym
2.10.1 GlycoZym Details
2.10.2 GlycoZym Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlycoZym SWOT Analysis
2.10.4 GlycoZym Product and Services
2.10.5 GlycoZym Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.11 Louisville Bioscience, Inc.
2.11.1 Louisville Bioscience, Inc. Details
2.11.2 Louisville Bioscience, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Louisville Bioscience, Inc. SWOT Analysis
2.11.4 Louisville Bioscience, Inc. Product and Services
2.11.5 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mayo Clinic US
2.12.1 Mayo Clinic US Details
2.12.2 Mayo Clinic US Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mayo Clinic US SWOT Analysis
2.12.4 Mayo Clinic US Product and Services
2.12.5 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lung Cancer Diagnostic Tests Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lung Cancer Diagnostic Tests Players Market Share
3.2.2 Top 10 Lung Cancer Diagnostic Tests Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lung Cancer Diagnostic Tests Revenue and Market Share by Regions
4.2 North America Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.3 Europe Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.5 South America Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
5 North America Lung Cancer Diagnostic Tests Revenue by Countries
5.1 North America Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
5.2 USA Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
5.3 Canada Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
5.4 Mexico Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
6 Europe Lung Cancer Diagnostic Tests Revenue by Countries
6.1 Europe Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
6.2 Germany Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.3 UK Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.4 France Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.5 Russia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.6 Italy Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Countries
7.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
7.2 China Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.3 Japan Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.4 Korea Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.5 India Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
8 South America Lung Cancer Diagnostic Tests Revenue by Countries
8.1 South America Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
8.2 Brazil Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
8.3 Argentina Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lung Cancer Diagnostic Tests by Countries
9.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.3 UAE Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.4 Egypt Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.5 South Africa Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2015-2020)
10.2 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2019-2024)
10.3 Immunoassays Revenue Growth Rate (2015-2025)
10.4 Flow Cytometry Revenue Growth Rate (2015-2025)
10.5 Rapid Tests Revenue Growth Rate (2015-2025)
10.6 Molecular Assays Revenue Growth Rate (2015-2025)
10.7 Tissue Arrays Revenue Growth Rate (2015-2025)
10.8 Circulating Tumor Cells Revenue Growth Rate (2015-2025)
10.9 Pharmacodiagnostics Revenue Growth Rate (2015-2025)
10.10 Biomarkers Revenue Growth Rate (2015-2025)
10.11 Other Diagnostics Methods Revenue Growth Rate (2015-2025)
11 Global Lung Cancer Diagnostic Tests Market Segment by Application
11.1 Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2015-2020)
11.2 Lung Cancer Diagnostic Tests Market Forecast by Application (2019-2024)
11.3 Precision Medicine Revenue Growth (2015-2020)
11.4 Personalized Medicine Revenue Growth (2015-2020)
11.5 Cancer Monitoring Revenue Growth (2015-2020)
12 Global Lung Cancer Diagnostic Tests Market Size Forecast (2021-2025)
12.1 Global Lung Cancer Diagnostic Tests Market Size Forecast (2021-2025)
12.2 Global Lung Cancer Diagnostic Tests Market Forecast by Regions (2021-2025)
12.3 North America Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
12.4 Europe Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
12.6 South America Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Lung Cancer Diagnostic Tests Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lung Cancer Diagnostic Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lung Cancer Diagnostic Tests Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lung Cancer Diagnostic Tests Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Advpharma Inc Corporate Information, Location and Competitors
Table 6. Advpharma Inc Lung Cancer Diagnostic Tests Major Business
Table 7. Advpharma Inc Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 8. Advpharma Inc SWOT Analysis
Table 9. Advpharma Inc Lung Cancer Diagnostic Tests Product and Solutions
Table 10. Advpharma Inc Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Epigenomics AG Corporate Information, Location and Competitors
Table 12. Epigenomics AG Lung Cancer Diagnostic Tests Major Business
Table 13. Epigenomics AG Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2018-2019)
Table 14. Epigenomics AG SWOT Analysis
Table 15. Epigenomics AG Lung Cancer Diagnostic Tests Product and Solutions
Table 16. Epigenomics AG Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. DiagnoCure Inc. (Inactive) Corporate Information, Location and Competitors
Table 18. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Major Business
Table 19. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 20. DiagnoCure Inc. (Inactive) SWOT Analysis
Table 21. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product and Solutions
Table 22. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AIT Austrian Institute of Technology GmbH Corporate Information, Location and Competitors
Table 24. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Major Business
Table 25. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 26. AIT Austrian Institute of Technology GmbH SWOT Analysis
Table 27. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product and Solutions
Table 28. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Emory University Corporate Information, Location and Competitors
Table 30. Emory University Lung Cancer Diagnostic Tests Major Business
Table 31. Emory University Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 32. Emory University SWOT Analysis
Table 33. Emory University Lung Cancer Diagnostic Tests Product and Solutions
Table 34. Emory University Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Courtagen Life Sciences Inc Corporate Information, Location and Competitors
Table 36. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Major Business
Table 37. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 38. Courtagen Life Sciences Inc SWOT Analysis
Table 39. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Solutions
Table 40. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. HalioDx SAS Corporate Information, Location and Competitors
Table 42. HalioDx SAS Lung Cancer Diagnostic Tests Major Business
Table 43. HalioDx SAS Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 44. HalioDx SAS SWOT Analysis
Table 45. HalioDx SAS Lung Cancer Diagnostic Tests Product and Solutions
Table 46. HalioDx SAS Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BioMarker Strategies LLC Corporate Information, Location and Competitors
Table 48. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Major Business
Table 49. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 50. BioMarker Strategies LLC SWOT Analysis
Table 51. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product and Solutions
Table 52. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BioMark Diagnostics Inc. Corporate Information, Location and Competitors
Table 54. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Major Business
Table 55. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 56. BioMark Diagnostics Inc. SWOT Analysis
Table 57. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product and Solutions
Table 58. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GlycoZym Corporate Information, Location and Competitors
Table 60. GlycoZym Lung Cancer Diagnostic Tests Major Business
Table 61. GlycoZym Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 62. GlycoZym SWOT Analysis
Table 63. GlycoZym Lung Cancer Diagnostic Tests Product and Solutions
Table 64. GlycoZym Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Louisville Bioscience, Inc. Corporate Information, Location and Competitors
Table 66. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Major Business
Table 67. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 68. Louisville Bioscience, Inc. SWOT Analysis
Table 69. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product and Solutions
Table 70. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Mayo Clinic US Corporate Information, Location and Competitors
Table 72. Mayo Clinic US Lung Cancer Diagnostic Tests Major Business
Table 73. Mayo Clinic US Lung Cancer Diagnostic Tests Total Revenue (USD Million) (2017-2018)
Table 74. Mayo Clinic US SWOT Analysis
Table 75. Mayo Clinic US Lung Cancer Diagnostic Tests Product and Solutions
Table 76. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Lung Cancer Diagnostic Tests Revenue (Million USD) by Players (2015-2020)
Table 78. Global Lung Cancer Diagnostic Tests Revenue Share by Players (2015-2020)
Table 79. Global Lung Cancer Diagnostic Tests Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Lung Cancer Diagnostic Tests Revenue Market Share by Regions (2015-2020)
Table 81. North America Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
Table 82. North America Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Table 83. Europe Lung Cancer Diagnostic Tests Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Lung Cancer Diagnostic Tests Revenue by Countries (2015-2020)
Table 86. South America Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Lung Cancer Diagnostic Tests Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Table 89. Global Lung Cancer Diagnostic Tests Revenue (Million USD) by Type (2015-2020)
Table 90. Global Lung Cancer Diagnostic Tests Revenue Share by Type (2015-2020)
Table 91. Global Lung Cancer Diagnostic Tests Revenue Forecast by Type (2021-2025)
Table 92. Global Lung Cancer Diagnostic Tests Revenue by Application (2015-2020)
Table 93. Global Lung Cancer Diagnostic Tests Revenue Share by Application (2015-2020)
Table 94. Global Lung Cancer Diagnostic Tests Revenue Forecast by Application (2021-2025)
Table 95. Global Lung Cancer Diagnostic Tests Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lung Cancer Diagnostic Tests Picture
Figure 2. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type in 2019
Figure 3. Immunoassays Picture
Figure 4. Flow Cytometry Picture
Figure 5. Rapid Tests Picture
Figure 6. Molecular Assays Picture
Figure 7. Tissue Arrays Picture
Figure 8. Circulating Tumor Cells Picture
Figure 9. Pharmacodiagnostics Picture
Figure 10. Biomarkers Picture
Figure 11. Other Diagnostics Methods Picture
Figure 12. Lung Cancer Diagnostic Tests Revenue Market Share by Application in 2019
Figure 13. Precision Medicine Picture
Figure 14. Personalized Medicine Picture
Figure 15. Cancer Monitoring Picture
Figure 16. Global Lung Cancer Diagnostic Tests Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Lung Cancer Diagnostic Tests Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Lung Cancer Diagnostic Tests Revenue Market Share in 2019
Figure 25. Global Top 10 Players Lung Cancer Diagnostic Tests Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Lung Cancer Diagnostic Tests Revenue Market Share by Regions (2015-2020)
Figure 29. Global Lung Cancer Diagnostic Tests Revenue Market Share by Regions in 2018
Figure 30. North America Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 31. Europe Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 33. South America Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 35. North America Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 36. North America Lung Cancer Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 37. USA Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 38. Canada Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 40. Europe Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Lung Cancer Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 42. Germany Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 43. UK Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 44. France Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 45. Russia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 46. Italy Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Lung Cancer Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 49. China Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 50. Japan Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 51. Korea Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 52. India Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 54. South America Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 55. South America Lung Cancer Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 56. Brazil Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Lung Cancer Diagnostic Tests Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Lung Cancer Diagnostic Tests Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 61. UAE Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Lung Cancer Diagnostic Tests Revenue and Growth Rate (2015-2020)
Figure 64. Global Lung Cancer Diagnostic Tests Revenue Share by Type (2015-2020)
Figure 65. Global Lung Cancer Diagnostic Tests Revenue Share by Type in 2019
Figure 66. Global Lung Cancer Diagnostic Tests Market Share Forecast by Type (2021-2025)
Figure 67. Global Immunoassays Revenue Growth Rate (2015-2020)
Figure 68. Global Flow Cytometry Revenue Growth Rate (2015-2020)
Figure 69. Global Rapid Tests Revenue Growth Rate (2015-2020)
Figure 70. Global Molecular Assays Revenue Growth Rate (2015-2020)
Figure 71. Global Tissue Arrays Revenue Growth Rate (2015-2020)
Figure 72. Global Circulating Tumor Cells Revenue Growth Rate (2015-2020)
Figure 73. Global Pharmacodiagnostics Revenue Growth Rate (2015-2020)
Figure 74. Global Biomarkers Revenue Growth Rate (2015-2020)
Figure 75. Global Other Diagnostics Methods Revenue Growth Rate (2015-2020)
Figure 76. Global Lung Cancer Diagnostic Tests Revenue Share by Application (2015-2020)
Figure 77. Global Lung Cancer Diagnostic Tests Revenue Share by Application in 2019
Figure 78. Global Lung Cancer Diagnostic Tests Market Share Forecast by Application (2021-2025)
Figure 79. Global Precision Medicine Revenue Growth Rate (2015-2020)
Figure 80. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 81. Global Cancer Monitoring Revenue Growth Rate (2015-2020)
Figure 82. Global Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Lung Cancer Diagnostic Tests Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Lung Cancer Diagnostic Tests Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 86. Europe Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 88. South America Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Lung Cancer Diagnostic Tests Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
肺がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lung Cancer Diagnostic Tests Scope and Market Size Lung C…- 子宮頸がん診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 8198.9 million by 2025, from USD 6937.9 million in 2019. The Cer…
- 肺がん診断の世界市場（～2026年） Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring. As people's awareness of cancer increases and techno…
- 乳癌スクリーニング検査の世界市場（～2026年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…